Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.

International journal of cardiology - 25 May 2005

Andreassi Maria Grazia, Botto Nicoletta, Laghi-Pasini Franco, Manfredi Samantha, Ghelarducci Bruno, Farneti Andrea, Solinas Marco, Biagini Andrea, Picano Eugenio

Abstract excerpt

BACKGROUND: C34T variant of adenosine monophosphate deaminase 1 (AMPD1) gene has been associated with a prolonged survival in heart failure and coronary artery disease, hypothetically linked to an enhanced production of adenosine. DESIGN: Since adenosine administration is a promising approach for the prevention of the ischemia-reperfusion in myocardial revascularization, the aim of this study was to investigate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine
Share to AMP Deaminase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Angioplasty, Balloon, Coronary

Share to Coronary Artery Bypass

Share to Coronary Artery Disease

Share to Follow-Up Studies

Share to Polymorphism, Genetic

Share to Treatment Outcome

Source

Identifiers

PMID: 15882662
DOI: 10.1016/j.ijcard.2004.03.014

Genes

AMPD1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.PMID 15882662Read ↗

A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.Semantic proximity Read ↗

A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction.Semantic proximity Read ↗

Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.Semantic proximity Read ↗

AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment.Semantic proximity Read ↗

Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.Semantic proximity Read ↗

Adenosine and cardioprotection: what can we learn from nature's genetic polymorphism?Semantic proximity Read ↗

The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.Semantic proximity Read ↗

The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.Semantic proximity Read ↗

Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.Semantic proximity Read ↗

Augmented hyperemia and reduced tissue injury in response to ischemia in subjects with the 34C > T variant of the AMPD1 geneSemantic proximity Read ↗

Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.Semantic proximity Read ↗

Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.